Clinical Trial Update: Oral Iron vs. Placebo in Newly Diagnosed Gynecologic Oncology Patients Who Are Surgical Candidates. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral iron to placebo in newly diagnosed gynecologic oncology patients who are surgical candidates; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cervical Cancer
• Ovarian Cancer
• Uterine Cancer

Drugs mentioned

• Oral iron (ferrous sulfate)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Ovarian Cancer, Cervical Cancer | Phase 4 | Status: COMPLETED